RE
Recce Pharmaceuticals Ltd
RECEF · OTC
$0.50 +127.27% (+$0.28)
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
48 /100
Moderate Beta 0.39x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre RECEF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Hamilton-Bray Graham
Employees
-
Headquarters
Sydney
Evenimente viitoare
01 MAR.
Earnings
Upcoming earnings report